Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Urinary Bladder, Superficial”

409 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 409 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03022825
What this trial is testing

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
ImmunityBio, Inc. 190
Testing effectiveness (Phase 2)UnknownNCT05957757
What this trial is testing

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

Who this might be right for
Non-Muscle Invasive Bladder CancerHER2
RenJi Hospital 20
Not applicableUnknownNCT05626101
What this trial is testing

Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study

Who this might be right for
Non-muscle-invasive Bladder Cancer
Al-Azhar University 280
Testing effectiveness (Phase 2)Study completedNCT00393809
What this trial is testing

Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer

Who this might be right for
Bladder Neoplasms
Hebrew University of Jerusalem 18
Not applicableAvailableNCT06443944
What this trial is testing

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Who this might be right for
Non-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more
CG Oncology, Inc.
Early research (Phase 1)WithdrawnNCT04109092
What this trial is testing

Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Who this might be right for
Urinary Bladder Neoplasms
Eisai Inc.
Not applicableWithdrawnNCT04583553
What this trial is testing

Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture

Who this might be right for
Urinary Tract InfectionsBladder Cancer
University of Kansas Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227065
What this trial is testing

Precise Neoadjuvant Chemoresection of Low Grade NMIBC

Who this might be right for
Bladder CancerNon-muscle Invasive Bladder CancerLow-risk
University of Bern 28
Testing effectiveness (Phase 2)Study completedNCT00002917
What this trial is testing

Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Testing effectiveness (Phase 2)Active Not RecruitingNCT04375813
What this trial is testing

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Who this might be right for
Non-muscle Invasive Bladder Cancer
Robert Svatek 166
Testing effectiveness (Phase 2)UnknownNCT02070120
What this trial is testing

Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer

Who this might be right for
Bladder Cancer
Institute of Cancer Research, United Kingdom 82
Large-scale testing (Phase 3)Study completedNCT00006034
What this trial is testing

Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Intracel
Early research (Phase 1)UnknownNCT03421236
What this trial is testing

Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Who this might be right for
Non Muscle Invasive Bladder Cancer
Patrice Jichlinski 25
Large-scale testing (Phase 3)Looking for participantsNCT06929286
What this trial is testing

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center 125
Large-scale testing (Phase 3)Study completedNCT07279792
What this trial is testing

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more
Ain Shams University 150
Testing effectiveness (Phase 2)Study completedNCT03892642
What this trial is testing

Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Oklahoma 18
Not applicableEnded earlyNCT04142359
What this trial is testing

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

Who this might be right for
Pharmacokinetics
Altor BioScience 1
Not applicableActive Not RecruitingNCT07252297
What this trial is testing

The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Xijing Hospital 177
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268339
What this trial is testing

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

Who this might be right for
High-Risk Non-Muscle Invasive Bladder Cancer
The Christie NHS Foundation Trust 328
Testing effectiveness (Phase 2)Study completedNCT02365818
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure

Who this might be right for
Bladder Cancer
CG Oncology, Inc. 66
Load More Results